About 100 reports

  • TUBERCULOSIS, PNEUMONIA, MRSA, SEPSIS, GLOBAL, PIPELINES BY MOLECULAR TARGET, 2017
  • 4.2.2 MRSA

Acquired Antibiotic Resistance Genes: An Overview.

  • Anti-Infective
  • Antibiotic Resistance
  • Infectious Disease
  • Therapy
  • Deals & Alliance
  • Jun 05, 2015: TAXIS Pharmaceuticals Announces Publication of Data Demonstrating Potential Viability of TXA709 in Combating Antibiotic Resistance
  • Apr 27, 2015: TAXIS Pharmaceuticals Demonstrates Clinical Potential of TXA709 in Combating Antibiotic Resistance

The molecules developed by companies in Phase I and Preclinical stages are ## and ## respectively.

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • Apr 27, 2015: TAXIS Pharmaceuticals Demonstrates Clinical Potential of TXA709 in Combating Antibiotic Resistance
  • Jun 05, 2015: TAXIS Pharmaceuticals Announces Publication of Data Demonstrating Potential Viability of TXA709 in Combating Antibiotic Resistance

The molecules developed by companies in Phase I stages are ## respectively.

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • APR 12, 2017: OPGEN TO PRESENT ANTIBIOTIC RESISTANCE PREDICTION DATA AT 25TH EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (ECCMID)
  • EQUITY OFFERING

Each unit consists of either one share of common stock, par value USD##. ## per share, or one share of non-voting, convertible preferred stock, and one warrant to acquire ##. ## of one share of common stock.

  • Antibiotic Resistance
  • Healthcare
  • Medical Equipment
  • United States
  • OpGen, Inc.
  • Apr 06, 2017: Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing

Unyvero System is a hardware platform used for the detection of a broad panel of bacteria, fungi and antibiotic resistances from a single sample in one run.

  • Antibiotic Resistance
  • Medical Device
  • Medical Equipment
  • United States
  • Curetis N.V.
  • ALGORITHM - BACTERIAL ANTIBIOTIC RESISTANCE
  • ALGORITHM - BACTERIAL ANTIBIOTIC RESISTANCE PRODUCT OVERVIEW

## Microbial Infections ## Staphylococcus Infection ## Enterovirus Infection ## Fungal Infections ## Gram Negative Bacterial Infection ## Antimicrobial Resistant Infections ## Indication No of Products OPGEN INC - PIPELINE ANALYSIS OVERVIEW BUS

  • Antibiotic Resistance
  • Healthcare
  • Hospital
  • United States
  • OpGen, Inc.
  • Nov 16, 2017: US FDA Grants Qualified Infectious Disease Product Designation for RECCE 327
  • Jan 18, 2017: Recce's lead compound reduces illness in mice infected by resistant E. coil bacteria

Antibiotic resistance has been called one of the biggest public health threats of our time.

  • Antibiotic Resistance
  • United States
  • World
  • Company
  • Product Initiative
  • Sep 30, 2017: Development of a negamycin analogue targeting the translational machinery in gram-negative drug-resistant pathogens for the treatment of Infections

Little is known about how exactly people become infected, and the bacteria are unusually adept at acquiring resistance to antibiotics.

  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • ContraFect Corporation

LIST OF FIGURES ##.

  • Antibiotic Resistance
  • United States
  • Forecast
  • Pfizer Inc.
  • Sanofi S.A.
  • EQUITY OFFERING
  • OPGEN RAISES USD10 MILLION IN PUBLIC OFFERING OF UNITS

GlobalData OpGen Inc reported one pharmaceuticals & healthcare deal worth $## million in YTD 2018.

  • Antibiotic Resistance
  • Healthcare
  • Pharmaceutical
  • United States
  • OpGen, Inc.
  • Official Title

The prominent features of this report are - ##.

  • Antibiotic Resistance
  • Clinical Trial
  • Drug Development
  • World
  • Product Initiative
  • Official Title

The prominent features of this report are - ##.

  • Anti-Infective
  • Antibiotic Resistance
  • Clinical Trial
  • Infectious Disease
  • World
  • ATLAS IO SYSTEM - BACTERIAL IDENTIFICATION AND ANTIBIOTIC RESISTANCE
  • ATLAS IO SYSTEM - BACTERIAL IDENTIFICATION AND ANTIBIOTIC RESISTANCE - PRODUCT STATUS

Luber has been appointed Chief Executive Officer effective ## October 2017.

  • Antibiotic Resistance
  • Diagnostics
  • United Kingdom
  • United States
  • World
  • Official Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Antibiotic Resistance
  • Clinical Trial
  • Therapy
  • World
  • Merck & Co., Inc.

The details ##.

  • Antibiotic Resistance
  • World
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

The combined OASIS-## and OASIS-## analysis showed that antibiotic resistance was common, occurring in ##. ## percent of S. aureus solates identified at baseline with more than one-third identified as MDR.

  • Antibiotic Resistance
  • Infectious Disease
  • Monoclonal Antibody
  • Vaccine
  • Paratek Pharmaceuticals, Inc.

The combined OASIS-## and OASIS-## analysis showed that antibiotic resistance was common, occurring in ##. ## percent of S. aureus solates identified at baseline with more than one-third identified as MDR.

  • Anti-Infective
  • Antibiotic Resistance
  • Therapy
  • United States
  • Product Initiative
  • 8.4.5.4.2 Antimicrobial Resistance Testing Market Revenue and Forecast to 2027 (US$ Mn)
  • Antimicrobial Resistance Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure ##. ##.

  • Antibiotic Resistance
  • World
  • Forecast
  • Market Size
  • Bruker Corporation
  • ANTHRAX - PIPELINE BY VENOMYX INC, H1 2020
  • SMALL MOLECULES TO INHIBIT LETHAL FACTOR FOR ANTHRAX AND CYSTIC FIBROSIS - DRUG PROFILE

Anthrax - Overview Anthrax - Therapeutics Development PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ANTHRAX, H## 2020 NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ANTHRAX, H## 2020 Phase III ## ## Phase II ## ## Phase I ## ## Preclinical ## ## Discovery ## ## Unknown ## ## Tot

  • Antibiotic Resistance
  • Therapy
  • United States
  • Company
  • Product Initiative

The combined OASIS-## and OASIS-## analysis showed that antibiotic resistance was common, occurring in ##. ## percent of S. aureus solates identified at baseline w ith more than one-third identified as MDR.

  • Antibiotic Resistance
  • Sexually Transmitted Disease
  • United States
  • Company
  • Product Initiative
  • Jan 18, 2017: Recce's lead compound reduces illness in mice infected by resistant E. coil bacteria
  • Jul 31, 2019: Carb-x funds BB100 to develop a unique monoclonal antibody to prevent and treat hypervirulent multi-drug-resistant e. Coli infections

Antibiotic resistance has been called one of the biggest public health threats of our time.

  • Antibiotic Resistance
  • Therapy
  • United States
  • Company
  • Product Initiative
  • ANTIBIOTIC RESISTANCE PANEL
  • ANTIBIOTIC RESISTANCE PANEL - PRODUCT DESCRIPTION

Notes Recent Development section covers news posted during last one year GlobalData considers regulatory approved (Approved and Issued) products as pipeline in case products are yet to launch in the market.

  • Antibiotic Resistance
  • Biotech Diagnostics
  • Diagnostics
  • Company
  • Product Initiative

The molecules developed by Companies in Phase II, Phase I, IND/ CTA Filed and Preclinical stages are ##, ##, ## and ## respectively.

  • Antibiotic Resistance
  • Therapy
  • United States
  • World
  • Product Initiative
  • Emergence of antibiotic resistance
  • MARKET CHALLENGES

You can easily book an appointment with one online.

  • Antibiotic Resistance
  • Danaher Corporation
  • Merck & Co., Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.

One unit refers to one POC analyzer.

  • Antibiotic Resistance
  • Clinical Trial
  • International University
  • United States
  • McKesson Corporation

The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ## and ## respectively.

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • Product Initiative
  • Basilea Pharmaceutica Ltd.

The combined OASIS-## and OASIS-## analysis showed that antibiotic resistance was common, occurring in ##. ## percent of S. aureus solates identified at baseline with more than one-third identified as MDR.

  • Antibiotic Resistance
  • Sexually Transmitted Disease
  • United States
  • Company
  • Product Initiative
  • Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Product Development Milestones

The molecules developed by Companies in Phase II, Preclinical and Unknown stages are ##, ## and ## respectively.

  • Antibiotic Resistance
  • Hospital
  • World
  • Product Initiative
  • MGB Biopharma Limited

ONE CBC REFERS TO ONE TEST.

  • Antibiotic Resistance
  • Healthcare
  • Germany
  • Western Europe
  • Merck & Co., Inc.
  • FEATURED NEWS & PRESS RELEASES
  • TRACK DESIGNATIONS. THE DESIGNATIONS WERE GRANTED FOR BOTH COMPLICATED URINARY TRACT INFECTIONS (CUTI) AND COMPLICATED INTRA-ABDOMINAL INFECTIONS (CIAI).

AERUGINOSA INFECTIONS OCCUR IN THE US EACH YEAR AND THE RATES OF ANTIBIOTIC RESISTANCE ARE INCREASING WORLDWIDE.

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative